| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Reed's, Inc.
13D/A
Amendment 2
REED · 758338305
|
57.8% |
6/11/2025
Event 6/4/2025
|
|||
| Era Regenerative Medicine Ltd | 57.8% | ||||
| D&D Source of Life Holding Ltd. | 57.8% | ||||
|
Reed's, Inc.
13D/A
Amendment 1
REED · 758338305
|
59.5% |
5/2/2025
Event 4/16/2025
|
|||
| Era Regenerative Medicine Ltd | 59.5% | ||||
| D&D Source of Life Holding Ltd. | 59.5% | ||||
|
Reed's, Inc.
13D
REED · 758338305
|
59.5% |
2/28/2025
Event 12/31/2024
|
|||
| Era Regenerative Medicine Ltd | 59.5% | ||||
| D&D Source of Life Holding Ltd. | 59.5% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.